After 48 weeks, 9 (39%) of the 23 patients who received liraglutide 1.8 mg daily and underwent a follow-up biopsy achieved MASH resolution, compared with only 2 (9%) of 22 patients in the placebo group ( P = .019)
These insights can support a more informed conversation with your provider about treatment suitability and potential response patterns
Hu, X., Zhang, Y., Xue, Y., Zhang, Z., & Wang, J
She told the workshop that the study will be completely remote, using self-draw devices for at-home blood collection, wearables for activity and sleep tracking, and scales to monitor weight loss to ensure patients remain in a healthy range
Small research studies and anecdotal clinical reports suggest that some people tolerate DSIP without major side effects, but standardized long-term safety studies do not exist